India to Brazil: Escitalopram Export Trade Route
India has recorded 125 verified shipments of Escitalopram exported to Brazil, representing a combined trade value of $5.9M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $47.6K USD. The leading Indian exporter is SANDOZ PRIVATE LIMITED, which accounts for 26% of total export value with 21 shipments worth $1.6M USD. On the buying side, M/S. RANBAXY FARMACEUTICA LTDA : is the largest importer in Brazil with $949.5K USD in purchases. The top 3 suppliers — SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 75% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Escitalopram corridor is one of India's established pharmaceutical export routes, with 125 shipments documented worth a combined $5.9M USD. The route is dominated by SANDOZ PRIVATE LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's escitalopram manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $47.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #9 among India's top escitalopram export destinations globally.
On the import side, key buyers of Indian escitalopram in Brazil include M/S. RANBAXY FARMACEUTICA LTDA : , SANDOZ DO BRASIL IND FARMACEUTICA, SANDOZ DO BRASIL IND FARMACEUTICA and 15 others. M/S. RANBAXY FARMACEUTICA LTDA : is the single largest importer with 23 shipments valued at $949.5K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDHANNAD ICD (INDHA6)
Market Position
- Global rank#9
- Annual growth+24.3%
- Demand growth+22.3%
- Regulatory ease69/100
Top 10 Indian Escitalopram Exporters to Brazil
Showing top 10 of 7 Indian suppliers exporting Escitalopram to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SANDOZ PRIVATE LIMITED Avg $74.4K per shipment | 21 | $1.6M | 26.3% |
| 2 | SANDOZ PRIVATE LIMITED Avg $102.7K per shipment | 15 | $1.5M | 25.9% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $40.4K per shipment | 33 | $1.3M | 22.4% |
| 4 | TORRENT PHARMACEUTICALS LTD Avg $31.5K per shipment | 13 | $409.8K | 6.9% |
| 5 | TORRENT PHARMACEUTICALS LTD Avg $55.6K per shipment | 7 | $389.4K | 6.6% |
| 6 | TORRENT PHARMACEUTICALS LIMITED Avg $28.2K per shipment | 13 | $366.5K | 6.2% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $14.9K per shipment | 23 | $343.4K | 5.8% |
This table shows the top 10 of 7 Indian companies exporting escitalopram to Brazil, ranked by total trade value. The listed exporters are: SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED , TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. SANDOZ PRIVATE LIMITED is the dominant supplier with 21 shipments worth $1.6M USD, giving it a 26% market share. The top 3 suppliers together account for 75% of the total trade value on this route.
Top 10 Escitalopram Importers in Brazil
Showing top 10 of 18 known buyers in Brazil receiving Escitalopram shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian escitalopram in Brazil include M/S. RANBAXY FARMACEUTICA LTDA : , SANDOZ DO BRASIL IND FARMACEUTICA, SANDOZ DO BRASIL IND FARMACEUTICA , SANDOZ DO BRASIL IND FARMAC?UTICA , TORRENT DO BRASIL LTDA, among 18 total buyers. The largest importer is M/S. RANBAXY FARMACEUTICA LTDA : , accounting for $949.5K USD across 23 shipments — representing 16% of all escitalopram imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S. RANBAXY FARMACEUTICA LTDA : | 23 | $949.5K | 16.0% |
| 2 | SANDOZ DO BRASIL IND FARMACEUTICA | 12 | $904.8K | 15.2% |
| 3 | SANDOZ DO BRASIL IND FARMACEUTICA | 8 | $875.3K | 14.7% |
| 4 | SANDOZ DO BRASIL IND FARMAC?UTICA | 7 | $664.9K | 11.2% |
| 5 | TORRENT DO BRASIL LTDA | 19 | $584.7K | 9.8% |
| 6 | TORRENT DO BRASIL LTDA | 6 | $389.3K | 6.5% |
| 7 | SANDOZ DO BRASIL IND FARMACEUTICA RUA ANTONIO RASTEIRO | 3 | $361.6K | 6.1% |
| 8 | SANDOZ DO BRASIL IND FARMAC?UTICA | 6 | $296.2K | 5.0% |
| 9 | M/S. RANBAXY FARMACEUTICA LTDA : | 5 | $257.4K | 4.3% |
| 10 | M/S. RANBAXYFARMACEUTICA LTDA | 3 | $225.6K | 3.8% |
Showing top 10 of 18 Escitalopram importers in Brazil on this route.
Top 10 Escitalopram Formulations Imported by Brazil
Showing top 10 of 75 product formulations shipped on the India to Brazil Escitalopram route, ranked by trade value
Brazil imports a wide range of escitalopram formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Material No. - 42030715, ESCITALOPRAM OX — accounts for $441.1K USD across 3 shipments. There are 75 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Material No. - 42030715, ESCITALOPRAM OX | 3 | $441.1K | 7.4% |
| 2 | Material No-42030715, ESCITALOPRAM OXA F | 2 | $333.5K | 5.6% |
| 3 | Material No - 42030715, ESCITALOPRAM OXA | 2 | $333.5K | 5.6% |
| 4 | ESCITALOPRAM OXALATE TABLETS 10MG PACK: | 5 | $297.8K | 5.0% |
| 5 | Material No.-42030715 ESCITALOPRAM OXAFCT 20MG IN91 SH MS BATCH NO.NH4516 NH4190NH4187NH4195NH4194NH3532 MANUFACTURING DATE | 1 | $254.3K | 4.3% |
| 6 | Material No 42030721 ESCITALOPRAM OXAFCT 10MG IN91 SH MS BATCH NO MV2415 MV2420 MV2417 MFG DATE 15 02 2023 DA | 2 | $242.2K | 4.1% |
| 7 | ESCITALOPRAM OXAL TAB 10MG PACK:BOX3X10s | 5 | $217.7K | 3.7% |
| 8 | OTHER - ESCITALOPRAM OXALATE 10MG TABLET | 2 | $201.0K | 3.4% |
| 9 | MATERIAL NO-42030715 ESCITALOPRAM OXA FCT 20MG IN91 SH MSPCS | 3 | $175.8K | 3.0% |
| 10 | ESCITALOPRAM OXALATE TABLETS 10MG PACK:4 | 3 | $154.3K | 2.6% |
Showing top 10 of 75 Escitalopram formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
DHANNAD ICD (INDHA6) handles the highest volume with 31 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's escitalopram exports to Brazil are driven primarily by a handful of large-scale manufacturers. SANDOZ PRIVATE LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 75% of total trade value on this route. The average shipment value of $47.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as material no-42030715, escitalopram oxa f and material no - 42030715, escitalopram oxa , suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S. RANBAXY FARMACEUTICA LTDA : is the largest importer with 23 shipments worth $949.5K USD — representing 16% of all escitalopram imports from India on this route. A total of 18 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.9M
- Avg. Shipment
- $47.6K
- Suppliers
- 7
- Buyers
- 18
- Transit (Sea)
- ~21 days
- Annual Growth
- +24.3%
Related Analysis
Reverse Direction
Brazil → India — Escitalopram (Import)Other Escitalopram Routes
Unlock the Full India to Brazil Escitalopram Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 125 shipments on this route.
Frequently Asked Questions — India to Brazil Escitalopram Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Escitalopram to Brazil?
The leading Indian exporters of Escitalopram to Brazil are SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED . SANDOZ PRIVATE LIMITED holds the largest market share at approximately 26% of total trade value on this route.
Q What is the total value of Escitalopram exports from India to Brazil?
India exports Escitalopram to Brazil worth approximately $5.9M USD across 125 recorded shipments. The average value per shipment is $47.6K USD.
Q Which ports does India use to ship Escitalopram to Brazil?
The most active port of origin is DHANNAD ICD (INDHA6) with 31 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Brazil for Escitalopram?
The average transit time for Escitalopram shipments from India to Brazil is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Brazil Escitalopram trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.3% with demand growth tracking at 22.3%. The route is ranked #9 among India's top Escitalopram export destinations globally.
Q How many suppliers are active on the India to Brazil Escitalopram route?
There are currently 7 active Indian suppliers exporting Escitalopram to Brazil. The market is moderately concentrated with SANDOZ PRIVATE LIMITED accounting for 26% of total shipment value.
Q Who are the main importers of Escitalopram from India in Brazil?
The leading importers of Indian Escitalopram in Brazil include M/S. RANBAXY FARMACEUTICA LTDA : , SANDOZ DO BRASIL IND FARMACEUTICA, SANDOZ DO BRASIL IND FARMACEUTICA , SANDOZ DO BRASIL IND FARMAC?UTICA , TORRENT DO BRASIL LTDA. M/S. RANBAXY FARMACEUTICA LTDA : is the largest buyer with 23 shipments worth $949.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Escitalopram.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 18 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 125 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
125 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists